AZD1775 Continued Access Study to Assess Safety and Tolerability for Patients Enrolled in AZD1775 Clinical Pharmacology Studies
Clinical trial NCT03313557 · COMPLETED
Trial details
- NCT number
- NCT03313557
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-27
- Primary completion
- 2019-05-17
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.